Mark Vignola | Executive Director, Corporate Development and IR |
Dr. Mark Pruzanski | CEO |
Jerry Durso | COO |
Sandip Kapadia | CFO |
Michael Yee | Jefferies |
Brian Abrahams | RBC Capital Markets |
Alethia Young | Cantor Fitzgerald |
Ritu Baral | Cowen |
Steven Seedhouse | Raymond James |
Ross Weinreb | Goldman Sachs |
Trevor Brown | Baird |
Jay Olson | Oppenheimer |
Yasmeen Rahimi | Roth Capital Partners |
Michael Morabito | Credit Suisse |
Good morning, ladies and gentlemen. And thank you for joining the Intercept Pharmaceuticals Fourth Quarter and Full Year 2018 Financial Results Conference Call. All participants are now in listen-only mode.
Following opening remarks, Intercept's management will open the lines for a question-and-answer period. Please be advised that this call is being recorded at the Company's request and a webcast of this call will be archived on the Company's website for approximately two weeks.